Search

Your search keyword '"Kvols L"' showing total 13 results
Start Over Author "Kvols L" Publication Type Electronic Resources
13 results on '"Kvols L"'

3. Phase 1 study of peptide receptor radionuclide therapy (PRRT) with [Y-90-DOTA,Tyr(3)]octreotide in patients with somatostatin receptor positive tumors

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Kvols, L, Barone, Raffaella, Bakker, WH, Lasher, J, Krenning, E., 16th IRIST Meeting, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Kvols, L, Barone, Raffaella, Bakker, WH, Lasher, J, Krenning, E., and 16th IRIST Meeting

Published
2003

4. Survival in patients with neuroendocrine tumors after treatment with [Y-90-DOTA,Tyr(3)]octreotide in a phase-1 study.

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Pauwels, Stanislas, Jamar, François, Kvols, L, Smith, C, Krenning, EP, 50th Annual Meeting of the Society-of-Nuclear-Medicine, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Pauwels, Stanislas, Jamar, François, Kvols, L, Smith, C, Krenning, EP, and 50th Annual Meeting of the Society-of-Nuclear-Medicine

Published
2003

5. Peptide receptor radionuclide therapy (PRRT) with Y-90-DOTA(0),Tyr(3)-octreotide (Y-Oc) and In-111-DTPA(0)-octreotide (In-Oc): Comparison of tumor response and toxicity.

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Pauwels, Stanislas, Jamar, François, Kvols, L, Bakker, WH, Smith, C, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Pauwels, Stanislas, Jamar, François, Kvols, L, Bakker, WH, Smith, C, and Krenning, EP

Published
2002

6. Phase I study of therapy with Y-90-SMT487 (octreother) in patients with somatostatin receptor (SS-R) positive tumors.

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Kvols, L, Bakker, WH, Smith, C, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Kvols, L, Bakker, WH, Smith, C, and Krenning, EP

Published
2002

7. Safety and efficacy of [Y-90-DOTA,Tyr(3)]-octreotide (Y-90-SMT487; OctreoTher) peptide receptor radionuclide therapy (PRRT). Preliminary results of a phase-1 study

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Bakker, WH, Norenberg, J, Smith, C, Stolz, B, Kvols, L, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Bakker, WH, Norenberg, J, Smith, C, Stolz, B, Kvols, L, and Krenning, EP

Published
2001

8. Targeted radiotherapy with Y-90-DOTA-TYR3-octreotide (Y-90-SMT487; OctreoTher (TM)): A phase I study.

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Jonard, P., Bakker, WH, Norenberg, J, Hadley, J, Smith, C, Kvols, L, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Valkema, R, Jamar, François, Pauwels, Stanislas, Jonard, P., Bakker, WH, Norenberg, J, Hadley, J, Smith, C, Kvols, L, and Krenning, EP

Published
2000

9. Metabolic effects of amino acids (AA) solutions infused for renal radioprotection.

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Barone, Raffaella, Pauwels, Stanislas, Jamar, François, De Camps, J, Smith, C, Kvols, L, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Barone, Raffaella, Pauwels, Stanislas, Jamar, François, De Camps, J, Smith, C, Kvols, L, and Krenning, EP

Published
2000

10. Tumor dosimetry based on PET Y-86-DOTA-Tyr3-octreotide (SMT487) and CT-scan predicts tumor response to Y-90-SMT487 (OctreoTher (TM)) therapy.

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Jonard, P., Jamar, François, Pauwels, Stanislas, Walrand, Stéphan, Collart, JP, Valkema, R, Bakker, W, Labar, Daniel, Smith, C, Kvols, L, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Jonard, P., Jamar, François, Pauwels, Stanislas, Walrand, Stéphan, Collart, JP, Valkema, R, Bakker, W, Labar, Daniel, Smith, C, Kvols, L, and Krenning, EP

Published
2000

11. Can In-111-DTPA-octreotide (In-oC) predict kidney and tumor exposure during treatment with Y-90-SMT487 (OctreoTher (TM))?

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Barone, Raffaella, Jamar, François, Pauwels, Stanislas, Walrand, Stéphan, Labar, Daniel, Carlier, Pascal, Smith, C, Kvols, L, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Barone, Raffaella, Jamar, François, Pauwels, Stanislas, Walrand, Stéphan, Labar, Daniel, Carlier, Pascal, Smith, C, Kvols, L, and Krenning, EP

Published
2000

12. Effect of peptide amount on biodistribution of Y-86-DOTA-Tyr(3)-octreotide (SMT487).

Author

UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Jonard, P., Jamar, François, Pauwels, Stanislas, Walrand, Stéphan, Labar, Daniel, Mathieu, I, Smith, C, Kvols, L, Krenning, EP, UCL - Cliniques universitaires Saint-Luc, UCL - MD/MINT - Département de médecine interne, Jonard, P., Jamar, François, Pauwels, Stanislas, Walrand, Stéphan, Labar, Daniel, Mathieu, I, Smith, C, Kvols, L, and Krenning, EP

Published
2000

13. Nuclear medicine imaging of breast cancer

Author

Van Eijck, C. H.J., Krenning, E. P., Kvols, L. K., Van Eijck, C. H.J., Krenning, E. P., and Kvols, L. K.

Abstract

The best hope for improving survival among breast cancer patients is early detection. Standard mammography is the diagnostic tool of choice for the early detection of small breast lesions. Since the introduction of film-screen mammography and new magnification techniques, modern mammography has improved significantly over the last few years. However, approximately 10-15% of all palpable carcinomas cannot be detected on mammography and the treatment outcome may be adversely affected when a biopsy is delayed because of a negative mammography. The main reason for these negative findings is that dense breast tissue, which is most often seen in young women, may obscure tumours. On the other hand, only 15-20% of breast biopsy specimens of non-palpable lesions detected by mammographic screening prove malignent. Thus the specificity of mammography in deciding to perform an excisional biopsy for histological diagnosis is poor. [...] Therefore, a number of new non-invasive imaging techniques are currently employed to improve the sensitivity of diagnosing a malignant or pre-malignant lesion without sacrificing specificity, and to detect axillary lymph node metastases in patients with clinically negative nodes. In this editorial, an overview will be given only of nuclear medicine techniques. Data on their usefulness for tumour detection, treatment evaluation and for choosing a specific treatment will be discussed.

Published
1996

Catalog

Books, media, physical & digital resources
See catalog results